Moreover, the availability of bulk plasmablast BCR sequences, as well as single-cell paired BCR sequences from patients with Lyme disease opens the door to detailed antibody reactivity profiles and links to disease manifestations [73]. This evidence concerns the gene BCR and Lyme disease.